Mydecine announces filing of patent application for psilocybin-based MYCO-003. Pre-clinical data is showing MYCO-003 to work better than pure psilocybin.
Exploring the companies and themes that make up this emerging and exciting new sector
Small Pharma Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy
Small Pharma shows DMT to be well-tolerated and safe for the study population as it moves forward toward a Phase IIa clinical trial.
Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism
A former Republican congresswoman is touting the therapeutic benefits of psychedelics, sharing the story of how a close family friend was able to recover from alcoholism with the help of psilocybin.
New neuroscience research suggests the cerebral cortex acts as the brain’s hourglass
No one can stay awake forever. While we’re awake, our need for sleep gradually increases.
Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation
Wesana Health committed to fund a MAPS study on MDMA for traumatic brain injury.
California Activists Cleared To Collect Signatures For Psilocybin Legalization Ballot Initiative
California activists are now cleared to begin collecting signatures for an initiative to legalize psilocybin mushrooms in the state.
AdvisorShares Launches Psychedelics ETF (Ticker: PSIL)
AdvisorShares' new psychedelics ETF commences trading today on the NYSE Arca Exchange (symbol "PSIL") with a focus on small-cap psychedelic stocks.
The Two-Pronged Psychedelics Solution To The Opioid Crisis
Clinical research is rapidly advancing in using psychedelic drugs to treat opioid addiction. However, psychedelics can also reduce opioid-related deaths as a SUBSTITUTE for opioids.
House Could Vote On Psychedelics Research For Military And Marijuana Banking As Part Of Defense Bill
House lawmakers have introduced a series of drug policy-related amendments to defense legislation, including proposals to facilitate research on the benefits of psychedelics for active duty military personnel and to protect banks that service state-legal marijuana businesses.
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
Compass Pathways acquires an unspecified IP portfolio of psychedelic and emphathogenic substances.
Detroit Voters Will Decide On Psychedelics Decriminalization Ballot Measure In November
Detroit could become one of the next Michigan cities to decriminalize psychedelics, with the reform proposal making the local ballot for this November.
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
Wesana looks to expand its TBI-based psychedelics research into MDMA, with a new research partnership with MAPS.